Newsfeeds - Spark Newswire

1 minute read

Wells Fargo Initiates Coverage On Halozyme Therapeutics with Overweight Rating, Announces Price Target of $65

Today, 7:03 AM

Wells Fargo analyst Mohit Bansal initiates coverage on Halozyme Therapeutics (NASDAQ:HALO) with a Overweight rating and announces Price Target of $65.

HALO

6 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 7:03 AM

On Friday, 68 companies reached new 52-week highs.

ABC

1 minute read

Analyst Ratings

4 Analysts Have This to Say About Halozyme Therapeutics

By Benzinga Insights

Today, 7:03 AM

Halozyme Therapeutics (NASDAQ:HALO) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

HALO

1 minute read

Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina

By Lisa Levin

Today, 7:03 AM

Rosenblatt boosted the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $118 to $103. Rosenblatt analyst Barton Crockett maintained the stock with a Neutral rating. Amazon shares fell 4.3% to close at $100.79 on Friday.

AMZN

2 minute read

Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

Today, 7:03 AM

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

AMRK

1 minute read

Halozyme Reaffirms FY22 Guidance

By Bill Haddad

Today, 7:03 AM

Financial Outlook for 2022 The Company is reiterating its financial guidance for 2022, which was last provided on August 9, 2022 as a result of the close of the Antares Pharma transaction

HALO

21 minute read

Earnings

Earnings Scheduled For November 8, 2022

By Benzinga Insights

Today, 7:03 AM

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.

ABCL

1 minute read

Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection

By Vandana Singh

Today, 7:03 AM

Argenx SE (NASDAQ: ARGX) has

ARGX

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 9, 2022

By Benzinga Insights

Today, 7:03 AM

Upgrades

ADCT

1 minute read

Earnings

Halozyme Therapeutics: Q2 Earnings Insights

By Benzinga Insights

Today, 7:03 AM

Halozyme Therapeutics (NASDAQ:HALO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

HALO